You are here
Flow Pharma, Inc.
Company Information
Information
UEI: N/A
# of Employees: 8
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Marburg Virus Prophylactic Medical Countermeasure
Amount: $537,470.00Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture t ...
STTRPhase II2020Department of Defense Office for Chemical and Biological Defense -
Marburg Virus Prophylactic Medical Countermeasure
Amount: $136,773.00Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine pl ...
STTRPhase I2018Department of Defense Office for Chemical and Biological Defense